Brief: Moberg Pharma Q4 EBITDA Loss Widens To SEK 8.0 Million

Moberg Pharma AB (publ)

13/02/2024 07:16

Feb 13 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q4 EBITDA SEK -8.0 MILLION (-4.0)
    * Q4 PROFIT AFTER TAX SEK -6.4 MILLION (-3.1)
    * Q4 DILUTED EARNINGS PER SHARE SEK -0.23 (-0.32)

Source text for Eikon:  ID:nWkrbmBLF3 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))